Related Experiment Video

Updated: May 1, 2026

Seven Steps to Stellate Cells
06:40

Seven Steps to Stellate Cells

Published on: May 10, 2011

33.7K

A Novel Anti-Fibrotic Role of G-Protein-Coupled Receptor 119 in Hepatic Stellate Cells

Jeongwoo Park1,2, Min Hoo Lee1, Hyun Young Kim1,3

  • 1College of Pharmacy, Research Institute of Pharmaceutical Sciences and Natural Product Research Institute, Seoul National University, Seoul 08826, Republic of Korea.

Insights

G-protein-coupled receptor 119 (GPR119) agonists show promise in treating liver fibrosis. These compounds inhibit hepatic stellate cell activation and reduce fibrotic markers by activating AMP-activated protein kinase (AMPK).

Area of Science:

  • Hepatology and Pharmacology
  • Cell Biology
  • Molecular Medicine

Background:

  • Liver fibrosis, a consequence of chronic liver injury, presents significant therapeutic challenges.
  • The role of G-protein-coupled receptor 119 (GPR119) in liver fibrogenesis is largely unexplored, despite its known metabolic functions.

Purpose of the Study:

  • To investigate the expression of GPR119 in hepatic stellate cells (HSCs).
  • To evaluate the anti-fibrotic potential of GPR119 agonists in vitro and in vivo.
  • To elucidate the underlying molecular mechanisms of GPR119-mediated anti-fibrotic effects.

Main Methods:

  • GPR119 expression was analyzed in mouse primary HSCs via immunostaining and RT-PCR.
  • Anti-fibrotic effects of GPR119 agonists (MBX-2982, GSK1292263) were tested in HSCs, LX-2 cells, and a carbon tetrachloride (CCl₄)-induced mouse model.
  • Molecular mechanisms involving TGFβ1 signaling, AMPK activation, and Smad3 acetylation were investigated.

Main Results:

  • GPR119 agonists inhibited HSC activation and suppressed TGFβ1-induced Smad2/3 phosphorylation.
  • In vivo, MBX-2982 reduced collagen deposition and key fibrotic markers in CCl₄-treated mice.
  • MBX-2982 activated AMPK, which was crucial for its anti-fibrotic activity, and reduced Smad3 acetylation by affecting p300 interactions.

Conclusions:

  • GPR119 plays a significant role in regulating HSC activation.
  • GPR119 agonists demonstrate potent anti-fibrotic properties.
  • Targeting GPR119 via agonists represents a promising therapeutic strategy for liver fibrosis.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
14.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.9K